I Tried 5 Different Copper Supplements for 30 Days — My Results
Quick Summary
After 30 days testing five distinct copper forms—copper bisglycinate, copper gluconate, copper sulfate, copper sebacate, and GHK-Cu copper peptide—copper bisglycinate emerged as the clear winner for bioavailability, tolerability, and measurable impact on ceruloplasmin and energy markers. Copper gluconate caused noticeable GI distress at 2 mg/day. GHK-Cu showed topical skin benefits but negligible systemic copper elevation. Bottom line: For systemic copper repletion, stick with chelated bisglycinate at 1–2 mg/day alongside zinc monitoring.
Why I Did This Experiment
Copper is the third most abundant trace mineral in the body, yet it’s arguably the most misunderstood. It’s essential for:
- Cytochrome c oxidase (Complex IV) — the terminal electron acceptor in mitochondrial ATP production
- Ceruloplasmin — the primary copper transport protein, also a ferroxidase critical for iron metabolism
- Superoxide dismutase (SOD1) — the primary cytosolic antioxidant enzyme
- Lysyl oxidase — cross-links collagen and elastin for vascular and skin integrity
- Dopamine β-hydroxylase — converts dopamine to norepinephrine
Despite this, copper supplementation remains controversial. The copper-zinc ratio (ideally 1:8 to 1:12) is frequently disrupted by high-dose zinc supplementation (>30 mg/day), which induces metallothionein and blocks copper absorption in enterocytes.
I’d been taking 30 mg zinc picolinate daily for immune support for 18 months. My last HTMA (Hair Tissue Mineral Analysis) showed copper at 8 ppm (reference 11–37 ppm) and zinc at 180 ppm (reference 140–220 ppm) — a copper:zinc ratio of 0.044, well below the 0.083–0.125 target. Serum ceruloplasmin was 18 mg/dL (reference 20–45 mg/dL). I needed to replete copper — but which form?
The 5 Forms Tested
| Form | Chemical Name | Elemental Cu per 2 mg | Cost/Month | Key Claim |
|---|---|---|---|---|
| Copper Bisglycinate | Copper bisglycinate chelate | 2 mg | $18 | Highest bioavailability, gentle on stomach |
| Copper Gluconate | Copper(II) gluconate | 2 mg | $12 | Common, inexpensive |
| Copper Sulfate | Copper(II) sulfate pentahydrate | 2 mg | $8 | Inorganic, used in agriculture |
| Copper Sebacate | Copper(II) sebacate | 2 mg | $22 | ”Copper(II) sebacate salicylate” — SOD mimetic |
| GHK-Cu (Copper Peptide) | Glycyl-L-histidyl-L-lysine-Cu²⁺ | ~0.5 mg* | $65 | Topical peptide, skin regeneration |
*GHK-Cu delivers ~0.5 mg elemental copper per 5 mg peptide; not designed for systemic repletion.
Protocol & Dosing Schedule
| Week | Form | Dose | Timing | Co-factors |
|---|---|---|---|---|
| 1 | Copper Bisglycinate | 2 mg/day | Breakfast + 15 mg zinc | 500 mg vitamin C, 200 mg magnesium glycinate |
| 2 | Copper Gluconate | 2 mg/day | Breakfast + 15 mg zinc | Same |
| 3 | Copper Sulfate | 2 mg/day | Breakfast + 15 mg zinc | Same |
| 4 | Copper Sebacate | 2 mg/day | Breakfast + 15 mg zinc | Same |
| Ongoing | GHK-Cu Topical | 5 mg/day (topical) | PM face/neck | N/A |
Washout: 48 hours between forms. Blood drawn at baseline, day 15, day 30, and day 45 (post-washout).
Tracking: Daily energy (1–10), sleep quality (Oura ring), skin elasticity (cutometer), stool consistency (Bristol scale), subjective “brain fog” score.
Results: Blood Work
| Marker | Baseline | Day 15 (Bisglycinate) | Day 30 (Sebacate) | Day 45 (Post) | Reference |
|---|---|---|---|---|---|
| Serum Copper | 72 µg/dL | 98 µg/dL ↑ | 105 µg/dL ↑ | 94 µg/dL | 70–140 µg/dL |
| Ceruloplasmin | 18 mg/dL | 26 mg/dL ↑ | 31 mg/dL ↑ | 28 mg/dL | 20–45 mg/dL |
| Serum Zinc | 92 µg/dL | 88 µg/dL | 85 µg/dL | 90 µg/dL | 60–120 µg/dL |
| Cu:Zn Ratio (serum) | 0.78 | 1.11 | 1.24 | 1.04 | 0.7–1.2 |
| HbA1c | 5.2% | 5.1% | 5.1% | 5.2% | <5.7% |
| Ferritin | 85 ng/mL | 78 ng/mL | 72 ng/mL | 80 ng/mL | 30–300 ng/mL |
Key finding: Ceruloplasmin rose 72% from baseline (18 → 31 mg/dL) by day 30, normalizing the copper-zinc ratio. Ferritin dipped slightly — consistent with ceruloplasmin’s ferroxidase activity mobilizing iron from storage.
Results: Subjective & Functional
| Metric | Baseline | Bisglycinate (Wk1) | Gluconate (Wk2) | Sulfate (Wk3) | Sebacate (Wk4) | GHK-Cu (Topical) |
|---|---|---|---|---|---|---|
| Energy (1–10) | 5.2 | 8.1 | 6.0 | 5.5 | 7.8 | 5.3 |
| Sleep Score (Oura) | 78 | 86 | 79 | 77 | 84 | 79 |
| Brain Fog (1–10, lower=better) | 6.0 | 2.5 | 4.8 | 5.2 | 3.0 | 5.5 |
| Skin Elasticity (mm) | 0.42 | 0.44 | 0.43 | 0.42 | 0.45 | 0.51 |
| GI Tolerance | — | ✅ None | ❌ Nausea, cramping | ❌ Metallic taste, loose stool | ✅ Mild | ✅ N/A |
| Stool (Bristol) | 4 | 4 | 5–6 | 5–6 | 4 | 4 |
Notable observations:
- Bisglycinate: Energy surge by day 4. Mental clarity improved dramatically — likely from restored dopamine β-hydroxylase activity (dopamine → norepinephrine).
- Gluconate: Day 2–3 nausea, mild epigastric cramping. Took with food — still occurred. Discontinued after day 5.
- Sulfate: Strong metallic taste within 30 min. Loose stools (Bristol 5–6) days 2–4. Felt “toxic” — consistent with inorganic copper’s redox activity generating hydroxyl radicals via Fenton-like reactions.
- Sebacate: Well-tolerated. Energy close to bisglycinate. Slightly better skin elasticity — sebacate may have SOD-mimetic activity per Free Radical Biology & Medicine 2018.
- GHK-Cu: Zero systemic effect on blood markers (as expected). Topical skin elasticity improved 21% — consistent with Journal of Drugs in Dermatology 2018 showing GHK-Cu upregulates collagen I/III and decorin.
Deep Dive: Why Bisglycinate Won
Absorption Mechanics
Copper absorption occurs primarily in the duodenum and proximal jejunum via CTR1 (copper transporter 1). The rate-limiting step is reduction of Cu²⁺ to Cu⁺ by STEAP (six-transmembrane epithelial antigen of prostate) reductases, followed by CTR1 transport.
Chelated forms (bisglycinate, sebacate) bypass the need for luminal reduction — the amino acid ligand stabilizes Cu²⁺ and delivers it to CTR1 as a neutral complex. Inorganic forms (sulfate, gluconate) require reduction first, exposing free Cu²⁺ to the lumen where it:
- Generates ROS via Fenton chemistry: Cu⁺ + H₂O₂ → Cu²⁺ + •OH + OH⁻
- Irritates gastric mucosa → nausea, gastritis
- Binds dietary phytates/fibers → reduced absorption
A 2014 Journal of Agricultural and Food Chemistry study found copper bisglycinate bioavailability 3.2× higher than copper sulfate in rats, with 89% less gastric mucosal damage.
The Zinc Interaction
I maintained 15 mg zinc (as picolinate) throughout — half my usual dose. This was intentional: zinc induces metallothionein in enterocytes, which binds copper with 1000× higher affinity than zinc, sequestering it and preventing basolateral export via ATP7A.
At 30 mg zinc/day, my copper absorption was effectively blocked. At 15 mg, absorption recovered — but copper bisglycinate’s chelation partially protects it from metallothionein sequestration, explaining its superior repletion despite concurrent zinc.
Comparison Table: All 5 Forms
| Criterion | Bisglycinate | Gluconate | Sulfate | Sebacate | GHK-Cu |
|---|---|---|---|---|---|
| Bioavailability | ⭐⭐⭐⭐⭐ | ⭐⭐⭐ | ⭐⭐ | ⭐⭐⭐⭐ | N/A (topical) |
| GI Tolerance | ⭐⭐⭐⭐⭐ | ⭐⭐ | ⭐ | ⭐⭐⭐⭐ | N/A |
| Ceruloplasmin Rise | +44% (Wk1) | +11% (Wk2*) | +8% (Wk3*) | +72% (Wk4) | 0% |
| Energy Improvement | ⭐⭐⭐⭐⭐ | ⭐⭐ | ⭐ | ⭐⭐⭐⭐ | ⭐ |
| Skin Benefits | ⭐⭐ | ⭐⭐ | ⭐ | ⭐⭐⭐ | ⭐⭐⭐⭐⭐ |
| Cost/Value | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | ⭐⭐⭐ | ⭐ |
| Best For | Systemic repletion | Budget (if tolerated) | Avoid | SOD support | Skin anti-aging |
*Gluconate/sulfate weeks truncated due to side effects; ceruloplasmin data reflects partial exposure.
Internal Links to Related Articles
- Copper-Zinc Balance Stacking Guide — How to dose copper and zinc together without inducing deficiency in either.
- Copper Bisglycinate vs Gluconate vs Sulfate Comparison — Deep dive on chemical forms, absorption pathways, and clinical data.
- Mineral Interaction Matrix Compatibility Chart — Full 15×15 mineral interaction grid including copper-iron, copper-molybdenum, copper-vitamin C.
FAQ
1. Can I just eat liver instead of supplementing copper?
Yes — but you’d need 3–4 oz beef liver weekly to match 2 mg/day supplemental copper. Liver also delivers retinol (vitamin A), B12, folate, heme iron, and cholesterol. If you eat liver weekly, test ceruloplasmin before supplementing. Excess copper + high retinol may accelerate hepatic stellate cell activation in susceptible individuals (Hepatology 2020).
2. Is copper sulfate dangerous at 2 mg/day?
Acute toxicity is unlikely at 2 mg elemental copper (LD₅₀ ~30 mg/kg in rats). However, chronic inorganic copper exposure — even at RDA levels — correlates with accelerated cognitive decline in the Journal of Alzheimer’s Disease 2013 (Morris et al.): copper from supplements (inorganic) + high saturated fat diet → 6× faster cognitive decline vs. dietary copper alone. This is why chelated forms are preferred for daily use.
3. Why did my ferritin drop during copper repletion?
Ceruloplasmin is a ferroxidase — it oxidizes Fe²⁺ to Fe³⁺ for transferrin binding. Low ceruloplasmin → iron trapped in macrophages/hepatocytes (high ferritin, low serum iron). Restoring ceruloplasmin mobilizes stored iron → transient ferritin drop. This is therapeutic, not adverse — it indicates functional copper status improvement. Monitor hemoglobin; if it drops, reduce copper dose.
4. Can I take copper and vitamin C together?
Yes, but separate by 2 hours if using high-dose vitamin C (>1 g). Ascorbate reduces Cu²⁺ to Cu⁺, which enhances absorption via CTR1 — but at very high doses, ascorbate can act as a pro-oxidant with free copper, generating hydroxyl radicals. With chelated copper (bisglycinate), this risk is minimal. I took 500 mg vitamin C with breakfast and copper — no issues.
5. How do I know if I’m copper toxic?
Wilson’s disease (ATP7B mutation) causes copper accumulation — but this is genetic, not supplement-induced. Acquired copper toxicity from supplements is rare below 10 mg/day chronic. Watch for: nausea, vomiting, abdominal pain, hemolytic anemia, elevated liver enzymes, psychiatric symptoms. Test: serum copper, ceruloplasmin, 24-hr urinary copper, non-ceruloplasmin-bound copper (free copper = total copper − 3.15 × ceruloplasmin). Free copper >25 µg/dL warrants investigation.
6. Does GHK-Cu peptide absorb systemically?
Minimally. A 2021 Pharmaceutical Research study using radiolabeled GHK-Cu showed <2% systemic absorption from topical application — most remains in stratum corneum/dermis. It acts locally on fibroblasts, keratinocytes, and mast cells. Do not rely on GHK-Cu for systemic copper repletion.
PubMed Citations
- Prohaska JR. “Functions of trace elements in brain metabolism.” Physiol Rev. 1987;67(3):858-901. PMID: 3303224.
- Olivares M, et al. “Copper bioavailability from copper bisglycinate chelate vs. copper sulfate in rats.” J Agric Food Chem. 2014;62(30):7421-7. PMID: 25004432.
- Morris MC, et al. “Copper intake and cognitive decline in older adults.” J Alzheimers Dis. 2013;37(3):547-55. PMID: 23948912.
- Pickart L, et al. “GHK-Cu peptide: mechanisms of action and clinical applications.” J Drugs Dermatol. 2018;17(6):675-682. PMID: 29874367.
- Linder MC, et al. “Ceruloplasmin: the copper transport protein with essential ferroxidase activity.” Am J Clin Nutr. 2020;111(4):837-845. PMID: 32107423.
- Zietz B, et al. “Copper-zinc ratio as a biomarker for cardiovascular risk.” Clin Chem Lab Med. 2022;60(5):712-720. PMID: 35113456.
- Stern BR, et al. “Copper-induced oxidative stress in the gastrointestinal tract.” Toxicol Sci. 2019;167(2):412-421. PMID: 30481312.
Final Verdict
| Goal | Recommended Form | Dose | Duration |
|---|---|---|---|
| Systemic repletion (low ceruloplasmin, high zinc) | Copper Bisglycinate | 1–2 mg/day | 3–6 months, retest |
| SOD support / oxidative stress | Copper Sebacate | 1–2 mg/day | 2–3 months |
| Skin anti-aging / wound healing | GHK-Cu Topical | 5 mg/day (topical) | Ongoing |
| Budget / maintenance (if tolerated) | Copper Gluconate | 1–2 mg/day | With food, monitor GI |
| Avoid | Copper Sulfate | — | — |
My protocol going forward: 2 mg copper bisglycinate at breakfast, 15 mg zinc picolinate at dinner (8-hr separation), ceruloplasmin + serum copper every 3 months. GHK-Cu serum nightly for skin.
Disclaimer: This N-of-1 experiment reflects personal experience and is not medical advice. Copper status varies by genetics (ATP7B, CTR1 polymorphisms), diet, zinc intake, and health conditions. Consult a qualified practitioner before starting copper supplementation, especially if you have Wilson’s disease, liver disease, or take medications affecting mineral metabolism.